A detailed history of Charles Schwab Investment Management Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 485,933 shares of CDNA stock, worth $14.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
485,933
Previous 568,500 14.52%
Holding current value
$14.4 Million
Previous $6.02 Million 25.35%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$7.56 - $16.15 $624,206 - $1.33 Million
-82,567 Reduced 14.52%
485,933 $7.55 Million
Q1 2024

May 08, 2024

BUY
$7.96 - $12.37 $991,425 - $1.54 Million
124,551 Added 28.06%
568,500 $6.02 Million
Q4 2023

Feb 06, 2024

BUY
$4.9 - $12.86 $165,458 - $434,243
33,767 Added 8.23%
443,949 $5.33 Million
Q3 2023

Nov 08, 2023

SELL
$7.0 - $11.26 $34,657 - $55,748
-4,951 Reduced 1.19%
410,182 $2.87 Million
Q2 2023

Aug 09, 2023

SELL
$7.61 - $9.46 $46,763 - $58,131
-6,145 Reduced 1.46%
415,133 $3.53 Million
Q1 2023

May 11, 2023

SELL
$8.83 - $17.61 $6,216 - $12,397
-704 Reduced 0.17%
421,278 $3.85 Million
Q4 2022

Feb 13, 2023

BUY
$10.88 - $20.05 $86,354 - $159,136
7,937 Added 1.92%
421,982 $4.81 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $158,560 - $260,548
9,873 Added 2.44%
414,045 $7.05 Million
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $99,396 - $192,681
-4,851 Reduced 1.19%
404,172 $8.68 Million
Q1 2022

May 13, 2022

BUY
$28.19 - $46.6 $343,100 - $567,168
12,171 Added 3.07%
409,023 $15.1 Million
Q4 2021

Feb 11, 2022

BUY
$41.2 - $73.6 $554,716 - $990,950
13,464 Added 3.51%
396,852 $18 Million
Q3 2021

Nov 16, 2021

BUY
$59.15 - $91.99 $354,367 - $551,112
5,991 Added 1.59%
383,388 $24.3 Million
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $582,493 - $879,101
-9,243 Reduced 2.39%
377,397 $34.5 Million
Q1 2021

May 17, 2021

BUY
$57.62 - $95.6 $581,789 - $965,273
10,097 Added 2.68%
386,640 $26.3 Million
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $396,112 - $737,057
9,561 Added 2.61%
376,543 $27.3 Million
Q3 2020

Nov 13, 2020

BUY
$30.88 - $37.94 $3.08 Million - $3.78 Million
99,666 Added 37.28%
366,982 $13.9 Million
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $484,020 - $904,953
25,542 Added 10.56%
267,316 $9.47 Million
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $176,145 - $356,967
-12,636 Reduced 4.97%
241,774 $5.28 Million
Q4 2019

Feb 07, 2020

SELL
$19.24 - $28.41 $188,936 - $278,986
-9,820 Reduced 3.72%
254,410 $5.49 Million
Q3 2019

Nov 08, 2019

BUY
$20.03 - $40.08 $2.39 Million - $4.79 Million
119,407 Added 82.45%
264,230 $5.98 Million
Q2 2019

Aug 09, 2019

BUY
$25.78 - $39.77 $261,460 - $403,347
10,142 Added 7.53%
144,823 $5.21 Million
Q1 2019

May 14, 2019

BUY
$22.09 - $39.21 $464,663 - $824,782
21,035 Added 18.51%
134,681 $4.25 Million
Q4 2018

Feb 14, 2019

BUY
$19.89 - $30.02 $420,156 - $634,142
21,124 Added 22.83%
113,646 $2.86 Million
Q3 2018

Nov 13, 2018

BUY
$12.1 - $28.85 $282,196 - $672,839
23,322 Added 33.7%
92,522 $2.67 Million
Q2 2018

Aug 08, 2018

BUY
$7.93 - $15.79 $548,756 - $1.09 Million
69,200 New
69,200 $848,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.59B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.